EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI ...

inserm-00431527, version 1 - 12 Nov 2009
assessment of disease damage and disease activity in Sjogren's syndrome, derived from an
analysis of a cohort of Italian patients. Arthritis Rheum 2007;56:2223-31.
17 Bowman SJ, Sutcliffe N, Isenberg DA, Goldblatt F, Adler M, Price E, et al. Sjogren's
Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in
clinical trials in primary Sjogren's syndrome. Rheumatology (Oxford) 2007;46:1845-51.
18 Gottenberg JE, Busson M, Cohen-Solal J, Lavie F, Abbed K, Kimberly RP, et al.
Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody
secretion and systemic involvement in primary Sjogren's syndrome. Ann Rheum Dis
2005;64:1050-5.
19 Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT.
Lymphoma and other malignancies in primary Sjogren's syndrome: a cohort study on cancer
incidence and lymphoma predictors. Ann Rheum Dis 2006;65:796-803.
20 Tzioufas AG, Boumba DS, Skopouli FN, Moutsopoulos HM. Mixed monoclonal
cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive
factors for the development of lymphoma in primary Sjogren's syndrome. Arthritis Rheum
1996;39:767-72.
21 Yohai VJ. High breakdown-point and high efficiency robust estimates for regression. Ann
Statist 1987;15:642-56.
22 Rousseeuw PJ. Least median of squares regression. J Am Stat Assoc 1984;79:871-80.
23 Marx RG, Menezes A, Horovitz L, Jones EC, Warren RF. A comparison of two time
intervals for test-retest reliability of health status instruments. J Clin Epidemiol 2003;56:730-
5.
24 Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods
Med Res 1999;8:135-60.
25 Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological
Measurement 1960;20:37-46.
26 Cohen J. Weighted kappa: nominal scale agreement with provision for scaled
disagreement or partial credit. Psychol Bull 1968;70:213-220.
27 Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York: Chapman and Hall,
1993.
28 Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, et al. Disease
activity in systemic lupus erythematosus: report of the Consensus Study Group of the
European Workshop for Rheumatology Research. II. Identification of the variables indicative
of disease activity and their use in the development of an activity score. The European
Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992;10:541-7.
29 Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the
SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in
SLE. Arthritis Rheum 1992;35:630-40.
30 Mahr AD, Neogi T, Lavalley MP, Davis JC, Hoffman GS, McCune WJ, et al. Assessment
of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's
granulomatosis. Arthritis Rheum 2008;59:884-91.
31 Symmons DP, Coppock JS, Bacon PA, Bresnihan B, Isenberg DA, Maddison P, et al.
Development and assessment of a computerized index of clinical disease activity in systemic
lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). Q J
Med 1988;69:927-37.
32 van der Heijde DM, van 't Hof M, van Riel PL, van de Putte LB. Development of a disease
activity score based on judgment in clinical practice by rheumatologists. J Rheumatol
1993;20:579-81.
18